ATM and cancer: As the ATM–CHK2–p53 axis is often mutated in human cancers the ATR–CHK1–Cdc25 pathway is the only route left for cancer cells to survive in an environment of proliferation-induced replicative stress or exogenously inflicted DNA damage.